David Marchionni

Title: David Marchionni: Innovator in Indolizine Derivatives

Introduction

David Marchionni is a notable inventor based in Antony, France. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on indolizine derivatives. His research focuses on the development of novel compounds that have potential therapeutic applications.

Latest Patents

David Marchionni holds a patent for "Indolizine derivatives, method for preparing same, and therapeutic compositions comprising same." This invention is directed to compounds of formula (I), which are described as novel indolizine derivatives. The patent outlines a method for their preparation along with pharmaceutical compositions that include these compounds, whose substituents are detailed in the specification. He has 1 patent to his name.

Career Highlights

Marchionni is currently employed at Sanofi-Aventis, a leading global healthcare company. His work at Sanofi-Aventis allows him to collaborate with other experts in the field and contribute to the advancement of pharmaceutical innovations.

Collaborations

Some of his notable coworkers include Patrick Gautier and Alain Roccon. Their collaboration enhances the research environment and fosters innovation within the company.

Conclusion

David Marchionni's contributions to the field of pharmaceuticals through his patent on indolizine derivatives exemplify his commitment to innovation. His work at Sanofi-Aventis and collaborations with esteemed colleagues further highlight his role as a significant inventor in the industry.